Design, synthesis, physicochemical, and pharmacological evaluation of gallic acid esters as non-ulcerogenic and gastroprotective anti-inflammatory agents

Medicinal Chemistry Research

Volumn 23, Issue 11, 2014, Pages 4771-4788

  Dhingra, Mamta Sachdeva ^a   Dhingra, Sameer ^b   Chadha, Renu ^a   Singh, Tejvir ^c   Karan, Maninder ^a  

^a PANJAB UNIVERSITY   (India)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^c PANJAB UNIVERSITY   (India)

Author keywords

ADME profiling; Anti inflammatory activity; Carrageenan induced paw edema; Enzymatic hydrolysis on human plasma; Gallic acid esters; Gastroprotective; Physicochemical; Ulcerogenic activity

Indexed keywords

EID: 84939880709     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-014-1041-x     Document Type: Article

References (46)

1. Bandyopadhyay U, Das D, Banerjee RK (1999) Reactive oxygen species - oxidative damage and pathogenesis. Curr Sci 77:658-665
2. Bhosle D, Bharambe S, Garrola N, Dhaneshwar SS (2006) Mutual prodrug concept: fundamentals and applications. Indian J Pharm Sci 68:286-294
3. Boelsterli UA (2002) Mechanisms of NSAID-induced hepatotoxicity. Drug Saf 25:633-648
4. Claiborne A (1985) Catalase activity. In: Greenwald RA (ed) Handbook of methods for oxygen radical research. CRC, Boca Raton, pp 283-284
5. Clark DE, Pickett SD (2000) Computational methods for the prediction of "drug-likeness". Drug Discov Today 5:49-58
6. Costa G, Francisco V, Lopes CM, Cruz TM, Batista TM (2012) Intracellular signaling pathways modulated by phenolic compounds: application for new anti-inflammatory drugs discovery. Curr Med Chem 19(18):2876-2900
7. Cotelle N (2001) Role of flavonoids in oxidative stress. Curr Top Med Chem 1:569-590
8. Dhingra MS, Deb PK, Chadha R, Singh TV, Karan M (2013) Synthesis, evaluation, and molecular docking studies of cycloalkyl/aryl-3,4,5-trimethylgallates as potent non-ulcerogenic and gastroprotective anti-inflammatory agents. Med Chem Res. doi:10.1007/s00044-013-0620-6
9. Dhingra MS, Dhingra S, Kumria R, Chadha R, Singh T, Kumar A, Karan M (2014) Effect of trimethylgallic acid esters against chronic stress-induced anxiety-like behavior and oxidative stress in mice. Pharmacol Rep. doi:10.1016/j.pharep.2014.01.004
10. Dodo K, Minato T, Noguchi-Yachide T, Suganuma M, Hashimoto Y (2008) Anti-proliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate. Bioorg Med Chem 16(17):7975-7982
11. Dogne JM, Supuran CT, Pratico D (2005) Adverse cardiovascular effects of coxibs. J Med Chem 48:2251-2257
12. Ghisalberti C (2008) Gallic acid esters of fragrant alcohols. Patent WO2008065527 A3
13. Hairsine P (1989) Direct measurement of partition coefficient by shake flask technique and gradient elution HPLC. Lab Pract 38:73-75
14. Henry D, McGettigan P (2003) Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs. Int J Clin Pract Suppl 135:43
15. Ihrman K, Malec R (1974) Phenol antioxidant-gallic acid ester stabilizer system. Patent US3792014A
16. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR (1974) Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic metabolite. Pharmacology 11:151-169
17. Kono Y (1978) Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189-195
18. Kroes BH, van den Berg AJ, Quarles van Ufford HC, van Dijk H, Labadie RP (1992) Anti-inflammatory activity of gallic acid. Planta Med 58:499-504
19. Laporte JR, Ibañez L, Vidal X, Vendrell L, Leone R (2004) Upper gastrointestinal bleeding associated with the use of NSAIDs. Drug Saf 27:411-420
20. Leppanen J, Huuskonen J, Nevalainen T, Gynther J, Taipale H, Jarvinen T (2002) Design and synthesis of a novel L-dopa entacapone codrug. J Med Chem 45:1379-1382
21. LigPrep, version 2.5, Schrödinger, LLC, New York, NY, 2011
22. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26
23. Lu Z, Nie G, Balton PS, Tang H, Zaho B (2006) Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 48:263-274
24. Madhukar M, Sawraj S, Sharma PD (2010) Design, synthesis and evaluation of mutual prodrug of 4-biphenylacetic acid and quercetin tetramethyl ether (BPA-QTME) as gastrosparing NSAID. Eur J Med Chem 45:2591-2596
25. Maestro, version 9.2, Schrödinger, LLC, New York, NY, 2011
26. Mahfouz NM, Aboul-Fadl T, Diab AK (1998) Metronidazole twin ester prodrugs: synthesis, physicochemical properties, hydrolysis kinetics and antigiardial activity. Eur J Med Chem 33(9):675-683
27. Martin MJ, La-casa C, Alarcon-de-la-Lastra C, Cabeza J, Villegas J, Motilva Y (1998) Antioxidant mechanisms involved in gastroprotective effects of quercetin. Z Naturforsch C 53:82-88
28. Milanino R, Concari E, Conforti A, Marrella M, Franco L, Moretti U, Velo G, Rainsford KD, Bressan M (1988) Synthesis and anti-inflammatory effect of some bis (2-benzimidazolyl) thiolethers and their copper(II) chelates, orally administered to rat. Eur J Med Chem 23:217-224
29. Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143-183
30. Pal C, Bindu S, Dey S, Alam A, Goyal M, Iqbal MS, Maity P, Adhikari SS, Bandyopadhyay U (2010) Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis. Free Radic Biol Med 49(2):258-267
31. Perron NR, Brumaghim JL (2009) A review of the iron-binding mechanism for polyphenol antioxidant activity. Cell Biochem Biophys 53:75-100
32. QikProp, version 3.4, Schrödinger, LLC, New York, NY, 2011
33. Rastogi L, Patnaik GK, Dikshit M (1998) Pylorus ligation induced gastric mucosal injury in rats. Pharmacol Res 38:125-132
34. Ravindranathan KP, Mandiyan V, Ekkati AR, Bae JH, Schlessinger J, Jorgensen WL (2010) Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening. J Med Chem 53:1662-1672
35. Sakaguchi N, Inoue M, Isuzugawa K, Ogihara Y, Hosaka K (1999) Cell death-inducing activity by gallic acid derivatives. Biol Pharm Bull 22:471-475
36. Sawraj S, Bhardawaj TR, Sharma PD (2012) Design, synthesis, and evaluation of novel indomethacin-antioxidant codrugs as gastrosparing NSAIDs. Med Chem Res 21:834-843
37. Schnitzer TJ (2001) COX-2-specific inhibitors: are they safe? J Am Med 110:46-49
38. Shay M, Kamarov SA, Fels D, Meraaze D, Gruenistein H, Siplet H (1945) A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 5:43-61
39. Singh G, Sharma PD (1994) Mutual prodrugs - a recent trend in prodrug design. Indian J Pharm Sci 56:69-79
40. Streng WH (ed) (2001) Characterization of compounds in solution theory and practice. Kluwer, New York
41. Wadhwa LK, Sharma PD (1995) Glycolamide esters of 6-methoxy-2-naphthylacetic acid as potential prodrugs - physicochemical properties, chemical stability and enzymatic hydrolysis. Int J Pharm 118:31-39
42. Wills ED (1965) Mechanisms of lipid peroxide formation in tissues role of metals and haematin proteins in the catalysis of the oxidation of unsaturated fatty acids. Biochim Biophys Acta 98:238-251
43. Winter CA, Risley GA, Nuss GW (1962) Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544-547
44. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of non steroidal anti-inflammatory drugs. N Engl J Med 340:1888-1899
45. Yalkowsky SH, Morozowich W (1980) A physical chemical basis for the design of orally active prodrugs. In: Ariens EJ (ed) Drug design, 9th edn. Academic Press, London, pp 121-185
46. Yalkowsky SH, Morzowich W, Banerjee S (eds) (1992) Aqueous solubility-methods of estimation for organic compounds. Marcel Dekker, New York